• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管手术期间肝素管理测试与活化凝血时间的比较:与抗Xa活性的相关性

Heparin management test versus activated coagulation time during cardiovascular surgery: correlation with anti-Xa activity.

作者信息

Fitch J C, Geary K L, Mirto G P, Byrne D W, Hines R L

机构信息

Department of Anesthesiology, Yale University School of Medicine, Yale-New Haven Hospital, CT, USA.

出版信息

J Cardiothorac Vasc Anesth. 1999 Feb;13(1):53-7. doi: 10.1016/s1053-0770(99)90174-x.

DOI:10.1016/s1053-0770(99)90174-x
PMID:10069285
Abstract

OBJECTIVE

To compare the abilities of the heparin management test (HMT) and the activated coagulation time (ACT) to provide a measurement of heparin effect in patients undergoing cardiac or peripheral vascular surgery. These measurements of heparin effect were also compared with measurements of heparin concentrations tested by anti-Xa activity. A secondary objective was to compare the performance of the noncitrated HMT with that of the citrated HMT.

DESIGN

A prospective study.

SETTING

A single-center study conducted in a university hospital.

PARTICIPANTS

After human investigation committee approval and informed consent were obtained, adult patients undergoing cardiac or peripheral vascular surgery were included in this study.

INTERVENTIONS

In both surgical groups, blood was sampled for ACT, HMT, and anti-Xa activity. Each HMT was performed on both noncitrated and citrated samples.

MEASUREMENTS AND MAIN RESULTS

As an indicator of heparin effect, the HMT had a strong correlation with the ACT (r = 0.899; p < 0.01). In addition, the HMT had a significantly stronger correlation with anti-Xa activity than the ACT (p < 0.01). The correlation obtained from the noncitrated samples was identical with that obtained from the citrated samples (r = 0.819; p < 0.001 for both groups).

CONCLUSION

The ability of the HMT and the ACT to measure heparin effect was similar. The HMT performed better than the ACT when using anti-Xa activity as a measure of heparin concentration. Noncitrated HMT results were similar to citrated HMT results, thus supporting the use of fresh whole blood for testing purposes.

摘要

目的

比较肝素管理试验(HMT)和活化凝血时间(ACT)在心脏或外周血管手术患者中测量肝素效果的能力。还将这些肝素效果测量值与通过抗Xa活性检测的肝素浓度测量值进行比较。次要目的是比较非枸橼酸化HMT与枸橼酸化HMT的性能。

设计

前瞻性研究。

地点

在一家大学医院进行的单中心研究。

参与者

在获得人类研究委员会批准并取得知情同意后,纳入接受心脏或外周血管手术的成年患者。

干预措施

在两个手术组中,采集血液用于ACT、HMT和抗Xa活性检测。每个HMT分别在非枸橼酸化和枸橼酸化样本上进行。

测量指标和主要结果

作为肝素效果的指标,HMT与ACT有很强的相关性(r = 0.899;p < 0.01)。此外,与ACT相比,HMT与抗Xa活性的相关性显著更强(p < 0.01)。从非枸橼酸化样本获得的相关性与从枸橼酸化样本获得的相关性相同(r = 0.819;两组p均< 0.001)。

结论

HMT和ACT测量肝素效果的能力相似。以抗Xa活性作为肝素浓度的测量指标时,HMT比ACT表现更好。非枸橼酸化HMT结果与枸橼酸化HMT结果相似,因此支持使用新鲜全血进行检测。

相似文献

1
Heparin management test versus activated coagulation time during cardiovascular surgery: correlation with anti-Xa activity.心血管手术期间肝素管理测试与活化凝血时间的比较:与抗Xa活性的相关性
J Cardiothorac Vasc Anesth. 1999 Feb;13(1):53-7. doi: 10.1016/s1053-0770(99)90174-x.
2
In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.在心脏手术期间,对抑肽酶治疗患者监测抗凝水平时,肝素管理试验与活化凝血时间的体内和体外评估。
Heart Surg Forum. 2004;7(6):E599-604. doi: 10.1532/HSF98.20041134.
3
Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.监测肝素与抑肽酶联合应用时的活化凝血时间:使用Sonoclot对一种新型抑肽酶不敏感检测方法的体内评估
Eur J Cardiothorac Surg. 2006 Aug;30(2):278-84. doi: 10.1016/j.ejcts.2006.05.016. Epub 2006 Jul 7.
4
Evaluation of a new point of care heparin test for cardiopulmonary bypass: the TAS heparin management test.用于体外循环的新型即时检测肝素检测方法的评估:TAS肝素管理检测
Perfusion. 2001 Mar;16(2):147-53. doi: 10.1177/026765910101600209.
5
Anticoagulation monitoring during vascular surgery: accuracy of the Hemochron low range activated clotting time (ACT-LR).血管手术期间的抗凝监测:Hemochron低范围活化凝血时间(ACT-LR)的准确性
Br J Anaesth. 2006 Oct;97(4):453-9. doi: 10.1093/bja/ael194. Epub 2006 Jul 27.
6
Heparin monitoring during cardiopulmonary bypass surgery using the one-step point-of-care whole blood anti-factor-Xa clotting assay heptest-POC-Hi.在体外循环手术期间使用一步即时全血抗Xa因子凝血测定法(HepTest - POC - Hi)进行肝素监测。
J Extra Corpor Technol. 2007 Jun;39(2):81-6.
7
Comparison of activated clotting times obtained using Hemochron and Medtronic analysers in patients receiving anti-thrombin therapy during cardiac catheterisation.在心脏导管插入术期间接受抗凝血酶治疗的患者中,使用Hemochron分析仪和美敦力分析仪获得的活化凝血时间的比较。
Thromb Haemost. 2009 Mar;101(3):535-40.
8
Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.行体外循环的婴幼儿的活化凝血时间值与肝素浓度测量值之间的相关性。
Anesth Analg. 2010 Jul;111(1):173-9. doi: 10.1213/ANE.0b013e3181e13470. Epub 2010 Jun 2.
9
The plasma supplemented modified activated clotting time for monitoring of heparinization during cardiopulmonary bypass: a pilot investigation.用于体外循环期间肝素化监测的血浆补充改良活化凝血时间:一项初步研究。
Anesth Analg. 2002 Jul;95(1):26-30, table of contents. doi: 10.1097/00000539-200207000-00004.
10
Monitoring high-dose heparin levels by ACT and HMT during extracorporeal circulation: diagnostic accuracy of three compact monitors.体外循环期间通过活化凝血时间(ACT)和肝素监测仪(HMT)监测高剂量肝素水平:三种紧凑型监测仪的诊断准确性
Perfusion. 2002 Jan;17(1):23-6. doi: 10.1191/0267659102pf530oa.

引用本文的文献

1
The hemostatic defect of cardiopulmonary bypass.体外循环的止血缺陷。
J Thromb Thrombolysis. 2003 Dec;16(3):129-47. doi: 10.1023/B:THRO.0000024051.12177.e9.
2
Point-of-Care Testing of Hemostasis in Cardiac Surgery.心脏手术中止血的床旁检测
Thromb J. 2003 May 6;1(1):1. doi: 10.1186/1477-9560-1-1.
3
Relationship between the heparin management test and the HemoTec activated clotting time in patients undergoing percutaneous coronary intervention.经皮冠状动脉介入治疗患者中肝素管理测试与HemoTec活化凝血时间的关系。
J Thromb Thrombolysis. 2001 May;11(3):217-21. doi: 10.1023/a:1011908803939.